Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Recognized as an Asia IP Elite for 2023, IPR Team adjudged as the Team of the Year’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.